Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Agomelatine Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102234238B reveals a mild Raney-Ni catalyzed route for Agomelatine intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN103113243A details a mild, high-yield route for Agomelatine intermediates. Discover cost-effective DDQ dehydrogenation and safe reduction strategies.
Patent CN102060733A reveals a high-yield synthesis for agomelatine intermediates using dual catalysis, offering significant cost reduction and scalable manufacturing solutions.
Patent CN107162933A reveals catalytic DDQ oxidation for high-purity pharmaceutical intermediates. Achieve cost reduction and scalable supply chain reliability.
Novel catalytic oxidative dehydrogenation route for Agomelatine intermediate. Lower cost, environmentally friendly, and scalable supply chain solutions.
Patent CN101486665B reveals a one-step ammonolysis route for 2-(7-methoxy-1-naphthyl)acetamide, offering significant cost reduction and environmental benefits for API manufacturing.
Discover a novel synthesis route for 7-methoxy-1-naphthylacetonitrile avoiding expensive DDQ and Pd/C. A cost-effective solution for agomelatine intermediate manufacturing.